Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Horie

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Case Reports in Endocrinology|October 24, 2012
A case of nonfunctioning pituitary carcinoma that responded to temozolomide treatmentHaruko Morokuma, Takao Ando, Takuya Hayashida, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 17, 2024
A Randomized Controlled Trial on the Effect of Luseogliflozin on Bone Microarchitecture Evaluated Using HR-pQCT in Elderly Type 2 DiabetesRiyoko Shigeno, Ichiro Horie, Ai Haraguchi, et al.
Endocrine Journal|September 23, 2020
A case of isolated hypothalamitis with a literature review and a comparison with autoimmune hypophysitisTetsuro Niri, Ichiro Horie, Hiromi Kawahara, et al.
Endocrine Journal|April 8, 2021
Bihormonal dysregulation of insulin and glucagon contributes to glucose intolerance development at one year post-delivery in women with gestational diabetes: a prospective cohort study using an early postpartum 75-g glucose tolerance testRiyoko Shigeno, Ichiro Horie, Masaki Miwa, et al.
Diabetes, Obesity & Metabolism|January 22, 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective studyYuta Nakamura, Ichiro Horie, Tadahiro Kitamura, et al.
Diabetologia|August 15, 2015
Haploinsufficiency of interferon regulatory factor 4 strongly protects against autoimmune diabetes in NOD miceSatoru Akazawa, Masakazu Kobayashi, Genpei Kuriya, et al.
Journal of Diabetes Investigation|December 28, 2020
Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance testAyako Ito, Ichiro Horie, Masaki Miwa, et al.
Diabetology International|January 22, 2021
Characteristics of patients who developed glucose intolerance in the early period after partial pancreatectomyNobuko Sera, Takeshi Nakamura, Ichiro Horie, et al.
Trials|May 7, 2020
The effect of luseogliflozin on bone microarchitecture in older patients with type 2 diabetes: study protocol for a randomized controlled pilot trial using second-generation, high-resolution, peripheral quantitative computed tomography (HR-pQCT)Ai Haraguchi, Riyoko Shigeno, Ichiro Horie, et al.
Endocrine Journal|November 26, 2025
Impacts of physical, metabolic, and immunological factors on the exophthalmometry values of a contemporary Japanese population with/without Graves' diseaseErika Nakaji, Yuta Nakamura, Ichiro Horie, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Case Reports in Endocrinology|October 24, 2012
A case of nonfunctioning pituitary carcinoma that responded to temozolomide treatmentHaruko Morokuma, Takao Ando, Takuya Hayashida, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 17, 2024
A Randomized Controlled Trial on the Effect of Luseogliflozin on Bone Microarchitecture Evaluated Using HR-pQCT in Elderly Type 2 DiabetesRiyoko Shigeno, Ichiro Horie, Ai Haraguchi, et al.
Endocrine Journal|September 23, 2020
A case of isolated hypothalamitis with a literature review and a comparison with autoimmune hypophysitisTetsuro Niri, Ichiro Horie, Hiromi Kawahara, et al.
Endocrine Journal|April 8, 2021
Bihormonal dysregulation of insulin and glucagon contributes to glucose intolerance development at one year post-delivery in women with gestational diabetes: a prospective cohort study using an early postpartum 75-g glucose tolerance testRiyoko Shigeno, Ichiro Horie, Masaki Miwa, et al.
Diabetes, Obesity & Metabolism|January 22, 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective studyYuta Nakamura, Ichiro Horie, Tadahiro Kitamura, et al.
Diabetologia|August 15, 2015
Haploinsufficiency of interferon regulatory factor 4 strongly protects against autoimmune diabetes in NOD miceSatoru Akazawa, Masakazu Kobayashi, Genpei Kuriya, et al.
Journal of Diabetes Investigation|December 28, 2020
Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance testAyako Ito, Ichiro Horie, Masaki Miwa, et al.
Diabetology International|January 22, 2021
Characteristics of patients who developed glucose intolerance in the early period after partial pancreatectomyNobuko Sera, Takeshi Nakamura, Ichiro Horie, et al.
Trials|May 7, 2020
The effect of luseogliflozin on bone microarchitecture in older patients with type 2 diabetes: study protocol for a randomized controlled pilot trial using second-generation, high-resolution, peripheral quantitative computed tomography (HR-pQCT)Ai Haraguchi, Riyoko Shigeno, Ichiro Horie, et al.
Endocrine Journal|November 26, 2025
Impacts of physical, metabolic, and immunological factors on the exophthalmometry values of a contemporary Japanese population with/without Graves' diseaseErika Nakaji, Yuta Nakamura, Ichiro Horie, et al.
Pageof 7